There is a newer version of the record available.

Published December 24, 2024 | Version v1
Journal article Open

BACTERIA ISOLATED FROM FEMALE PATIENTS WITH URINARY TRACT INFECTION AND ANTIBIOTIC RESISTANCE DISTRIBUTION: INTEGRATED MEDICINE APPROACH TO INFECTION MANAGEMENT

Creators

  • 1. Integrative Medicine Research Center

Description

Urinary tract infections (UTIs) are one of the most common infectious diseases in the community. The ongoing misuse of antimicrobials has led to the rise of bacterial resistance, a worldwide problem. The aim of this study was to examine the distribution and antibiotic resistance profiles of pathogens commonly found in female patients with urinary tract infections and to provide potential benefits of integrative treatment strategies. The study was conducted on female patients diagnosed with urinary tract infection who applied to the “Bioloji Tababat” clinic in Baku between June 2023 and July 2024. Etiological profiles and antibiotic resistance rates of bacteria ranked according to different age categories were analyzed. The study included 233 female patients with clinical urinary tract infection. Of these, 165 (70.8%) were positive for gram-negative bacteria and 68 (29.2%) were positive for 
gram-positive bacteria only for Staphylococcus aureus. The most common gram-negative uropathogen was E. coli (n = 114; 48.9). E. coli showed higher susceptibility to meropenem (96.5%), amikacin (99.1%), tobramycin (98.2%), nitrofurantoin (96.5%) and piperacillin/tazobactam (98.2%). The highest resistance rate of K. pneumoniae was detected against ampicillin and imipenem (100%). S.aureus was most susceptible to nitrofuran (97.1%) and tigecycline (98.6%). The highest number of E. coli was found in the 19-29 age group (60.5%, 69/114), followed by the 0-18 (12.2%, 14/114) and ≥60 age groups (12.2%, 14/114). The second most common organism in the 19-29 age group was S. aureus 58.8% (40/68), followed by K. pneumoniae 55.5% (10/18). A significant 
association was found between the 0-18, 19-29, 30-39 and ≥60 age groups in terms of bacterial isolates (p <0.05). The results of the study highlight the challenges of antibiotic resistance in the treatment of UTI and the potential contribution of integrative treatment approaches to this process.

Files

Annali d’Italia №62 2024-59-65.pdf

Files (756.7 kB)

Name Size Download all
md5:a1753b703bc168cf307052e5fe1b4961
756.7 kB Preview Download

Additional details

References

  • 1. Mancuso, Giuseppe, et al. "Urinary tract infections: the current scenario and future prospects." Pathogens 12.4 (2023): 623. 2. Gajdács, Márió, et al. "Increasing relevance of Gram-positive cocci in urinary tract infections: a 10- year analysis of their prevalence and resistance trends." Scientific reports 10.1 (2020): 17658. 3. Fazly Bazzaz, Bibi Sedigheh, et al. "Deep insights into urinary tract infections and effective natural remedies." African Journal of Urology 27 (2021): 1-13. 4. Medina-Polo, Jose, Kurt G. Naber, and Truls E. Bjerklund Johansen. "Healthcare-associated urinary tract infections in urology." GMS infectious diseases 9 (2021). 5. Mahony, Michelle, et al. "Multidrug-resistant organisms in urinary tract infections in children." Pediatric Nephrology 35.9 (2020): 1563-1573. 6. Kaur, Rajanbir, and Rajinder Kaur. "Symptoms, risk factors, diagnosis and treatment of urinary tract infections." Postgraduate medical journal 97.1154 (2021): 803-812. 7. Behzadi, Payam, et al. "The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options." Advances in Microbiology, Infectious Diseases and Public Health: Volume 15 (2021): 35-69. 8. Abraham, O. "Appropriate therapy for carbapenem-resistant Enterobacteriaceae (CRE)." International Journal of Infectious Diseases 45 (2016): 5. 9. Stapleton, A. E. (2016). The vaginal microbiome, bacterial vaginosis, and contributing factors to recurrent urinary tract infections. Translational Research, 175, 76-82. 10. Aggarwal, Nishant, Stephen Leslie, and Saran Lotfollahzadeh. "Recurrent urinary tract infections." StatPearls (2024). 11. Ventola, C. Lee. "The antibiotic resistance crisis: part 1: causes and threats." Pharmacy and therapeutics 40.4 (2015): 277. 12. Al-Zahrani, J., Al Dossari, K., Gabr, A. H., Ahmed, A. F., Al Shahrani, S. A., and Al-Ghamdi, S. (2019). Antimicrobial resistance patterns of Uropathogens isolated from adult women with acute uncomplicated cystitis. BMC Microbiol. 19:237. doi: 10.1186/s12866-019-1612-6 13. McGuire, Shelley. "World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency for research on cancer, WHO Press, 2015." Advances in nutrition 7.2 (2016): 418-419. 14. Gupta, K., Bhadelia, N., Walters, M. S. (2017). Antimicrobial resistance among uropathogens causing community-acquired urinary tract infections. Infectious Disease Clinics of North America,31(3), 303-315. 15. Goossens, W. J. H., et al. "Urological anomalies in anorectal malformations in The Netherlands: effects of screening all patients on long-term outcome." Pediatric surgery international 27 (2011): 1091-1097. 16. Carvalho, Fabio M., et al. "Effect of Lactobacillus plantarum biofilms on the adhesion of Escherichia coli to urinary tract devices." Antibiotics 10.8 (2021): 966.
  • 17. Sangeetha, Geminiganesan, and Ramesh Babu. "Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children." Pediatric Nephrology 37.10 (2022): 2277-2287. 18. Howell, Amy B., et al. "Differences in P-Type and Type 1 Uropathogenic Escherichia coli Urinary Anti-Adhesion Activity of Cranberry Fruit Juice Dry Extract Product and D-Mannose Dietary Supplement." Journal of Dietary Supplements (2024): 1-27. 19. Gonzalez, Michael J., J. Miranda–Massari, and J. Rodriguez. "Antiviral mechanisms of Vitamin C: A short communication consensus report." J. Orthomol. Med 35 (2020): 1-5. 20. Andersen, Marissa Jeme, et al. "Inhibiting host-protein deposition on urinary catheters reduces associated urinary tract infections." Elife 11 (2022): e75798. 21. Sami, H., Sultan, A., Rizvi, M., Khan, F., Ahmad, S., Shukla, I., et al. (2017). Citrobacter as a uropathogen, its prevalence and antibiotics susceptibility pattern. CHRISMED. J. Health Res. 4, 23–26. doi: 10.4103/2348-3334.196037 22. Elder, David E., et al. "The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway." Archives of pathology & laboratory medicine 144.4 (2020): 500- 522. 23. Bhargava, Kanika, et al. "Bacterial profile and antibiotic susceptibility pattern of uropathogens causing urinary tract infection in the eastern part of Northern India." Frontiers in Microbiology 13 (2022): 965053. 24. Ahmed, S. S., Shariq, A., Alsalloom, A. A., Babikir, I. H., and Alhomoud, B. N. (2019). Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. Int. J. Health Sci. 13, 48–55 25. Moue, A., Aktaruzzaman, S. A., Ferdous, N., Karim, M. R., Khalil, M. M., and Das, A. K. (2015). Prevalence of urinary tract infection in both outpatient department and inpatient department at a medical college setting of Bangladesh. Int. J. Biosci. 7, 146–152. doi: 10.12692/ijb/7.5.146-152 26. Arora, G., Kaur, P., and Agrawal, D. (2016). Urinary tract infection in women of the rural population of Haryana: A rising problem. Int. J. Reprod. Contracept. Obstet. Gynecol. 5, 4470–4474. doi: 10.18203/2320-1770.ijrcog20164365 27. Odoki, M., Almustapha, A. A., Tibyangye, J., Nyabayo, M. J., Wampande, E., Drago Kato, C., et al. (2019). Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda. Int. J. Microbiol. 2019:4246780 28. Chen, H. E., Tain, Y. L., Kuo, H. C., and Hsu, C. N. (2020). Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018. Antibiotics 9:501. 29. Daoud, N., Hamdoun, M., Hannachi, H., Gharsallah, C., Mallekh, W., and Bahri, O. (2020). Antimicrobial Susceptibility Patterns of Escherichia coli among Tunisian Outpatients with Community-Acquired Urinary Tract Infection (2012- 2018). Curr. Urol. 14, 200–205. doi: 10.1159/000499238 30. Ali, A. H., Reda, D. Y., and Ormago, M. D. (2022). Prevalence and antimicrobial susceptibility pattern of urinary tract infection among pregnant women attending Hargeisa Group Hospital, Hargeisa, Somaliland. Sci. Rep. 12:1419. 31. Huang, L., Huang, C., Yan, Y., Sun, L., and Li, H. (2022). Urinary Tract Infection Etiological Profiles and Antibiotic Resistance Patterns Varied Among Different Age Categories: A Retrospective Study from a Tertiary General Hospital During a 12-Year Period. Front. Microbiol. 12:813145. doi: 10.3389/fmicb.2021. 813145 32. Jagadeesan, S., Tripathi, B. K., Patel, P., and Muthathal, S. (2022). Urinary tract infection and Diabetes Mellitus—Etio-clinical profile and antibiogram: A North Indian perspective. J. Fam. Med. Prim. Care 11, 1902–1906. doi: 10.4103/jfmpc. jfmpc_2017_21 33. Komagamine, J., Yabuki, T., Noritomi, D., and Okabe, T. (2022). Prevalence of and factors associated with atypical presentation in bacteremic urinary tract infection. Sci. Rep. 12:5197. 34. Terlizzi, M. E., Gribaudo, G., and Maffei, M. E. (2017). UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front. Microbiol. 8:1566. doi: 10.3389/fmicb.2017.01566 35. Ben Ayed, H., Koubaa, M., Hammami, F., Marrakchi, C., Rekik, K., Ben Jemaa, T., et al. (2019). Performance of an Easy and Simple New Scoring Model in Predicting Multidrug-Resistant Enterobacteriaceae in Community-Acquired Urinary Tract Infections. Open Forum Infect. Dis. 6:ofz103. 36. Malik, S., Rana, J. S., and Nehra, K. (2021). Prevalence and antibiotic susceptibility pattern of uropathogenic Escherichia coli strains in Sonipat region of Haryana in India. Biomed. Biotechnol. Res. J. 5, 80– 87. 37. Shilpakar, A., Ansari, M., Rai, K. R., Rai, G., and Rai, S. K. (2021). Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gramnegative isolates from clinical samples in a tertiary care hospital of Nepal. Trop. Med. Health 49:23. 38. Gharavi, M. J., Zarei, J., Roshani-Asl, P., Yazdanyar, Z., Sharif, M., and Rashidi, N. (2021). Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples. Sci. Rep. 11:578 39. Naushad, V. A., Purayil, N. K., Wilson, G. J., Chandra, P., Joseph, P., Khalil, Z., et al. (2022). Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a casecontrol study from Qatar. IJID Reg. 3, 278–286. doi: 10.1016/j.ijregi.2022.0 5.001 40. Sadeghi, M., Ebrahim-Saraie, H. S., and Mojtahedi, A. (2022). Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran. New Microbes New Infect. 45:100947